US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kalvista Pharmaceuticals Inc

17.00

+0.57003.47%

Post-market: 17.000.00000.00%19:30 EDT

Volume:1.38M

Turnover:23.35M

Market Cap:859.29M

PE:-4.31

High:17.21

Open:16.79

Low:16.27

Close:16.43

52wk High:19.00

52wk Low:9.24

Shares:50.55M

Float Shares:27.81M

Volume Ratio:1.66

T/O Rate:4.97%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.9460

EPS(LYR):-3.6945

ROE:-190.18%

ROA:-60.98%

PB:21.07

PE(LYR):-4.60

Loading ...

Overview Company News Filings

Kalvista Pharmaceuticals Inc - Qtrly Net Loss per Share, Basic and Diluted $0.92

THOMSON REUTERS

Kalvista Pharmaceuticals Inc - Net Product Revenue $13.7 Mln in Q3

THOMSON REUTERS

Top News Today/Canada: Barrick's Interim CEO Gets to Work

KalVista Unveils New Data Showing High Patient Satisfaction With Oral HAE Drug EKTERLY

KalVista Pharmaceuticals to Present at Stifel Healthcare Conference

Kalvista Pharmaceuticals Inc. to Release Third Quarter Financial Results

Kalvista Pharmaceuticals to Host Third Quarter Financial Results Conference Call and Webcast on November 11, 2025

THOMSON REUTERS

KalVista price target lowered to $29 from $36 at BofA

BofA Securities Adjusts KalVista Pharmaceuticals Price Target to $29 From $36, Maintains Buy Rating

MT Newswires Live

Kalvista Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $29 From $36

THOMSON REUTERS

KalVista Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Operations Officer Arif Bilal

KalVista Pharmaceuticals Announces Positive Clinical Data and European Launch of EKTERLY®, the First Oral On-Demand Treatment for Hereditary Angioedema

KalVista Pharmaceuticals Appoints Bilal Arif as COO and Linea Aspesi as Chief People Officer Amid Global EKTERLY Launch

Kalvista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer

THOMSON REUTERS

KalVista Pharmaceuticals Grants Stock Options to New Employees Under Inducement Equity Incentive Plan

KalVista Pharmaceuticals Appoints Bethany L. Sensenig to Board of Directors and Audit Committee

Kalvista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors

THOMSON REUTERS

H.C. Wainwright Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)

KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, with Option for Additional $15 Million

KalVista Pharmaceuticals Announces New Clinical Data on EKTERLY® (Sebetralstat) for Hereditary Angioedema at German Allergy Congress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KALV/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KALV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KALV\",,,,,undefined,":{"symbol":"KALV","market":"US","secType":"STK","nameCN":"Kalvista Pharmaceuticals Inc","latestPrice":17,"timestamp":1774036800000,"preClose":16.43,"halted":0,"volume":1382705,"hourTrading":{"tag":"盘后","latestPrice":17,"preClose":17,"latestTime":"19:30 EDT","volume":114109,"amount":1940123.9246,"timestamp":1774049437997,"change":0,"changeRate":0,"amplitude":0.029412},"delay":0,"changeRate":0.03469263542300671,"floatShares":27812263,"shares":50546293,"eps":-3.946012,"marketStatus":"Market Closed","change":0.57,"latestTime":"03-20 16:00:00 EDT","open":16.785,"high":17.21,"low":16.27,"amount":23353379.997265,"amplitude":0.057212,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.946012,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1479790800000,"exchange":"NASDAQ","adjPreClose":16.43,"preHourTrading":{"tag":"盘前","latestPrice":16.6,"preClose":16.43,"latestTime":"09:29 EDT","volume":7898,"amount":129252.831378,"timestamp":1774013399517,"change":0.17,"changeRate":0.010347,"amplitude":0.149726},"postHourTrading":{"tag":"盘后","latestPrice":17,"preClose":17,"latestTime":"19:30 EDT","volume":114109,"amount":1940123.9246,"timestamp":1774049437997,"change":0,"changeRate":0,"amplitude":0.029412},"volumeRatio":1.6617094111299902,"impliedVol":0.3719,"impliedVolPercentile":0.0996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KALV\",,,,,undefined,":{"symbol":"KALV","floatShares":27812263,"roa":"-60.98%","roe":"-190.18%","lyrEps":-3.694529,"volumeRatio":1.6617094111299902,"shares":50546293,"dividePrice":0,"high":17.21,"amplitude":0.057212,"preClose":16.43,"low":16.27,"week52Low":9.235,"pbRate":"21.07","psRate":"602.59","week52High":19,"institutionHeld":0,"latestPrice":17,"eps":-3.946012,"divideRate":0,"volume":1382705,"delay":0,"ttmEps":-3.946012,"open":16.785,"prevYearClose":16.15,"prevWeekClose":16.94,"prevMonthClose":16.28,"prevQuarterClose":16.15,"fiveDayClose":16.94,"twentyDayClose":15.83,"sixtyDayClose":15.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KALV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-08","symbol":"KALV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1767848400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-10","symbol":"KALV","fiscalQuarterEnding":"2025/09","expectedEps":-0.96,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.92},{"market":"US","date":"2025-09-11","symbol":"KALV","fiscalQuarterEnding":"2025/07","expectedEps":-0.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1757563200000,"reportTimeType":"pre","actualEps":-1.12},{"market":"US","date":"2025-07-10","symbol":"KALV","fiscalQuarterEnding":"2025/04","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1752120000000,"reportTimeType":"pre","actualEps":-0.99},{"market":"US","date":"2025-03-12","symbol":"KALV","fiscalQuarterEnding":"2025/01","expectedEps":-0.89,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"pre","actualEps":-0.92}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KALV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KALV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.5556,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1738382400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KALV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KALV","date":"2026-03-20","current":-4.308147,"percent":0.409127,"low":-20.436544,"twenty":-5.279687,"median":-3.839524,"eighty":-3.035234,"high":-1.157457,"avg":-4.983672,"sd":3.561552,"marketCap":830475593},"quantilePoints":[{"date":"2021-03-26","current":-17.971835,"twenty":-21.214778,"median":-9.540006,"eighty":-5.797608,"marketCap":680629348},{"date":"2021-04-01","current":-17.625236,"twenty":-21.149559,"median":-9.55135,"eighty":-5.814845,"marketCap":667502924},{"date":"2021-04-09","current":-16.78441,"twenty":-20.99371,"median":-9.556921,"eighty":-5.818293,"marketCap":635659194},{"date":"2021-04-16","current":-15.693263,"twenty":-20.976773,"median":-9.61126,"eighty":-5.832083,"marketCap":594335269},{"date":"2021-04-23","current":-15.7061,"twenty":-20.967275,"median":-9.612147,"eighty":-5.83668,"marketCap":594821433},{"date":"2021-04-30","current":-16.027026,"twenty":-20.940526,"median":-9.678093,"eighty":-5.856215,"marketCap":606975529},{"date":"2021-05-07","current":-16.187489,"twenty":-20.9218,"median":-9.704874,"eighty":-5.863141,"marketCap":613052577},{"date":"2021-05-14","current":-16.726644,"twenty":-20.857283,"median":-9.745168,"eighty":-5.877022,"marketCap":633471457},{"date":"2021-05-21","current":-16.811935,"twenty":-20.83323,"median":-9.785618,"eighty":-5.896668,"marketCap":636701587},{"date":"2021-05-28","current":-17.41167,"twenty":-20.75174,"median":-9.79099,"eighty":-5.90442,"marketCap":659414763},{"date":"2021-06-04","current":-17.04409,"twenty":-20.626124,"median":-9.799069,"eighty":-5.913345,"marketCap":645493784},{"date":"2021-06-11","current":-18.533755,"twenty":-20.586034,"median":-9.811455,"eighty":-5.918271,"marketCap":701910381},{"date":"2021-06-18","current":-18.075893,"twenty":-20.520152,"median":-9.843589,"eighty":-5.941255,"marketCap":684570215},{"date":"2021-06-25","current":-18.030752,"twenty":-20.513378,"median":-9.870785,"eighty":-5.97573,"marketCap":682860621},{"date":"2021-07-02","current":-15.115909,"twenty":-20.487751,"median":-9.886663,"eighty":-5.97573,"marketCap":572469705},{"date":"2021-07-09","current":-14.806368,"twenty":-20.470471,"median":-9.906604,"eighty":-5.980327,"marketCap":560746776},{"date":"2021-07-16","current":-11.577795,"twenty":-20.442465,"median":-9.931245,"eighty":-6.013653,"marketCap":535403539},{"date":"2021-07-23","current":-11.239603,"twenty":-20.41703,"median":-9.935195,"eighty":-6.024733,"marketCap":519764184},{"date":"2021-07-30","current":-10.642482,"twenty":-20.36895,"median":-10.02465,"eighty":-6.037857,"marketCap":492150948},{"date":"2021-08-06","current":-10.526229,"twenty":-20.35815,"median":-10.080791,"eighty":-6.080593,"marketCap":486774920},{"date":"2021-08-13","current":-10.203889,"twenty":-20.33223,"median":-10.138374,"eighty":-6.114291,"marketCap":471868660},{"date":"2021-08-20","current":-9.728714,"twenty":-20.32575,"median":-10.088058,"eighty":-6.156324,"marketCap":449894651},{"date":"2021-08-27","current":-11.134384,"twenty":-20.299987,"median":-10.138374,"eighty":-6.165345,"marketCap":514898441},{"date":"2021-09-03","current":-10.706341,"twenty":-20.267469,"median":-10.155617,"eighty":-6.18096,"marketCap":495104053},{"date":"2021-09-10","current":-9.578084,"twenty":-20.245297,"median":-10.155617,"eighty":-6.21797,"marketCap":493644893},{"date":"2021-09-17","current":-9.12763,"twenty":-20.213596,"median":-10.138374,"eighty":-6.250384,"marketCap":470428920},{"date":"2021-09-24","current":-8.795716,"twenty":-20.155294,"median":-10.088058,"eighty":-6.257279,"marketCap":453322414},{"date":"2021-10-01","current":-8.217238,"twenty":-20.10972,"median":-10.041851,"eighty":-6.264174,"marketCap":423508217},{"date":"2021-10-08","current":-8.250429,"twenty":-20.053588,"median":-10.013512,"eighty":-6.268771,"marketCap":425218868},{"date":"2021-10-15","current":-8.160338,"twenty":-20.004942,"median":-9.935195,"eighty":-6.268771,"marketCap":420575673},{"date":"2021-10-22","current":-7.965932,"twenty":-19.978678,"median":-9.928498,"eighty":-6.275666,"marketCap":410556148},{"date":"2021-10-29","current":-8.525443,"twenty":-19.922322,"median":-9.903412,"eighty":-6.280263,"marketCap":439392830},{"date":"2021-11-05","current":-8.610793,"twenty":-19.879677,"median":-9.877142,"eighty":-6.281869,"marketCap":443791646},{"date":"2021-11-12","current":-8.378453,"twenty":-19.831313,"median":-9.856541,"eighty":-6.336494,"marketCap":431817092},{"date":"2021-11-19","current":-7.875841,"twenty":-19.770206,"median":-9.839276,"eighty":-6.372197,"marketCap":405912954},{"date":"2021-11-26","current":-7.150372,"twenty":-19.735066,"median":-9.812511,"eighty":-6.376794,"marketCap":368523019},{"date":"2021-12-03","current":-5.86065,"twenty":-19.683562,"median":-9.803588,"eighty":-6.374313,"marketCap":302052023},{"date":"2021-12-10","current":-5.440776,"twenty":-19.629284,"median":-9.79099,"eighty":-6.281333,"marketCap":330587011},{"date":"2021-12-17","current":-5.315932,"twenty":-19.592093,"median":-9.785618,"eighty":-6.268771,"marketCap":323001373},{"date":"2021-12-23","current":-5.815308,"twenty":-19.526544,"median":-9.758677,"eighty":-6.25482,"marketCap":353343926},{"date":"2021-12-31","current":-5.328014,"twenty":-19.427593,"median":-9.73108,"eighty":-6.165345,"marketCap":323735467},{"date":"2022-01-07","current":-5.231361,"twenty":-19.359562,"median":-9.678449,"eighty":-6.028583,"marketCap":317862714},{"date":"2022-01-14","current":-5.050136,"twenty":-19.275966,"median":-9.669428,"eighty":-5.97573,"marketCap":306851304},{"date":"2022-01-21","current":-4.675604,"twenty":-19.226786,"median":-9.61126,"eighty":-5.917549,"marketCap":284094389},{"date":"2022-01-28","current":-4.719904,"twenty":-19.038973,"median":-9.602702,"eighty":-5.872455,"marketCap":286786067},{"date":"2022-02-04","current":-5.311905,"twenty":-18.920681,"median":-9.559118,"eighty":-5.832083,"marketCap":322756675},{"date":"2022-02-11","current":-6.064996,"twenty":-18.894886,"median":-9.554037,"eighty":-5.832083,"marketCap":368515203},{"date":"2022-02-18","current":-6.26233,"twenty":-18.813739,"median":-9.549042,"eighty":-5.832083,"marketCap":380505405},{"date":"2022-02-25","current":-6.471745,"twenty":-18.753258,"median":-9.540006,"eighty":-5.850469,"marketCap":393229702},{"date":"2022-03-04","current":-6.330792,"twenty":-18.736138,"median":-9.503773,"eighty":-5.859533,"marketCap":384665271},{"date":"2022-03-11","current":-5.161388,"twenty":-18.734061,"median":-9.482882,"eighty":-5.850469,"marketCap":377720709},{"date":"2022-03-18","current":-5.245231,"twenty":-18.656282,"median":-9.460337,"eighty":-5.814845,"marketCap":383856523},{"date":"2022-03-25","current":-5.372673,"twenty":-18.605577,"median":-9.448647,"eighty":-5.750642,"marketCap":393182961},{"date":"2022-04-01","current":-5.030593,"twenty":-18.569418,"median":-9.418556,"eighty":-5.678382,"marketCap":368148840},{"date":"2022-04-08","current":-4.758941,"twenty":-18.547457,"median":-9.395816,"eighty":-5.640723,"marketCap":348268802},{"date":"2022-04-14","current":-4.815954,"twenty":-18.537748,"median":-9.373611,"eighty":-5.601865,"marketCap":352441156},{"date":"2022-04-22","current":-4.564425,"twenty":-18.461984,"median":-9.338328,"eighty":-5.560538,"marketCap":334033714},{"date":"2022-04-29","current":-4.269296,"twenty":-18.405112,"median":-9.313117,"eighty":-5.535966,"marketCap":312435648},{"date":"2022-05-06","current":-3.809836,"twenty":-18.394768,"median":-9.281755,"eighty":-5.492046,"marketCap":278811388},{"date":"2022-05-13","current":-3.25647,"twenty":-18.327474,"median":-9.263667,"eighty":-5.467356,"marketCap":238315015},{"date":"2022-05-20","current":-3.025063,"twenty":-18.279297,"median":-9.242266,"eighty":-5.434907,"marketCap":221380169},{"date":"2022-05-27","current":-3.011648,"twenty":-18.229202,"median":-9.214148,"eighty":-5.406406,"marketCap":220398438},{"date":"2022-06-03","current":-3.018356,"twenty":-18.162264,"median":-9.191891,"eighty":-5.383999,"marketCap":220889304},{"date":"2022-06-10","current":-2.800363,"twenty":-18.10833,"median":-9.167406,"eighty":-5.36913,"marketCap":204936187},{"date":"2022-06-17","current":-3.0586,"twenty":-18.095239,"median":-9.157656,"eighty":-5.356176,"marketCap":223834494},{"date":"2022-06-24","current":-3.464402,"twenty":-18.072024,"median":-9.140421,"eighty":-5.344467,"marketCap":253531834},{"date":"2022-07-01","current":-3.320191,"twenty":-18.052442,"median":-9.131967,"eighty":-5.332091,"marketCap":242978234},{"date":"2022-07-08","current":-3.303411,"twenty":-18.03602,"median":-9.129602,"eighty":-5.315932,"marketCap":271999553},{"date":"2022-07-15","current":-3.679409,"twenty":-18.030752,"median":-9.12698,"eighty":-5.299824,"marketCap":302958851},{"date":"2022-07-22","current":-4.013629,"twenty":-17.971835,"median":-9.097738,"eighty":-5.27566,"marketCap":330478228},{"date":"2022-07-29","current":-3.685377,"twenty":-17.837971,"median":-9.072071,"eighty":-5.232449,"marketCap":303450269},{"date":"2022-08-05","current":-4.106137,"twenty":-17.837971,"median":-9.006003,"eighty":-5.206415,"marketCap":338095198},{"date":"2022-08-12","current":-4.422453,"twenty":-17.837971,"median":-8.885027,"eighty":-5.187177,"marketCap":364140323},{"date":"2022-08-19","current":-4.479151,"twenty":-17.837971,"median":-8.802132,"eighty":-5.165186,"marketCap":368808788},{"date":"2022-08-26","current":-4.855149,"twenty":-17.837971,"median":-8.802132,"eighty":-5.148547,"marketCap":399768087},{"date":"2022-09-02","current":-4.816355,"twenty":-17.837971,"median":-8.754215,"eighty":-5.136538,"marketCap":396573874},{"date":"2022-09-09","current":-4.373534,"twenty":-17.837971,"median":-8.667692,"eighty":-5.127353,"marketCap":390434105},{"date":"2022-09-16","current":-4.131019,"twenty":-17.837971,"median":-8.653467,"eighty":-5.107209,"marketCap":368784324},{"date":"2022-09-23","current":-3.654257,"twenty":-17.837971,"median":-8.653467,"eighty":-5.104328,"marketCap":326222824},{"date":"2022-09-30","current":-3.998738,"twenty":-17.837971,"median":-8.653467,"eighty":-5.102379,"marketCap":356975353},{"date":"2022-10-07","current":-1.364146,"twenty":-17.837971,"median":-8.653467,"eighty":-5.092671,"marketCap":121780013},{"date":"2022-10-14","current":-1.256668,"twenty":-17.837971,"median":-8.653467,"eighty":-5.077139,"marketCap":112185224},{"date":"2022-10-21","current":-1.207062,"twenty":-17.837971,"median":-8.639242,"eighty":-5.053179,"marketCap":107756860},{"date":"2022-10-28","current":-1.408239,"twenty":-17.837971,"median":-8.551485,"eighty":-5.032505,"marketCap":125716337},{"date":"2022-11-04","current":-1.438554,"twenty":-17.837971,"median":-8.509961,"eighty":-5.025059,"marketCap":128422560},{"date":"2022-11-11","current":-1.515717,"twenty":-17.837971,"median":-8.469306,"eighty":-5.015017,"marketCap":135311126},{"date":"2022-11-18","current":-1.402728,"twenty":-17.837971,"median":-8.406531,"eighty":-4.990348,"marketCap":125224297},{"date":"2022-11-25","current":-1.430286,"twenty":-17.837971,"median":-8.383195,"eighty":-4.979261,"marketCap":127684499},{"date":"2022-12-02","current":-1.482647,"twenty":-17.837971,"median":-8.383195,"eighty":-4.97089,"marketCap":132358883},{"date":"2022-12-09","current":-1.532606,"twenty":-17.837971,"median":-8.383195,"eighty":-4.958632,"marketCap":140815818},{"date":"2022-12-16","current":-1.508491,"twenty":-17.837971,"median":-8.383195,"eighty":-4.945952,"marketCap":138600184},{"date":"2022-12-23","current":-1.369164,"twenty":-17.837971,"median":-8.383195,"eighty":-4.937657,"marketCap":125798746},{"date":"2022-12-30","current":-2.509054,"twenty":-17.837971,"median":-8.383195,"eighty":-4.919678,"marketCap":230531865},{"date":"2023-01-06","current":-2.471938,"twenty":-17.837971,"median":-8.383195,"eighty":-4.911339,"marketCap":227121631},{"date":"2023-01-13","current":-2.635249,"twenty":-17.837971,"median":-8.383195,"eighty":-4.865413,"marketCap":242126663},{"date":"2023-01-20","current":-2.761444,"twenty":-17.837971,"median":-8.383195,"eighty":-4.846147,"marketCap":253721461},{"date":"2023-01-27","current":-3.017546,"twenty":-17.837971,"median":-8.383195,"eighty":-4.818838,"marketCap":277252081},{"date":"2023-02-03","current":-2.921043,"twenty":-17.837971,"median":-8.383195,"eighty":-4.787017,"marketCap":268385470},{"date":"2023-02-10","current":-2.954448,"twenty":-17.837971,"median":-8.383195,"eighty":-4.759049,"marketCap":271454682},{"date":"2023-02-17","current":-3.013834,"twenty":-17.837971,"median":-8.383195,"eighty":-4.738746,"marketCap":276911057},{"date":"2023-02-24","current":-2.783714,"twenty":-17.837971,"median":-8.383195,"eighty":-4.719904,"marketCap":255767602},{"date":"2023-03-03","current":-3.032392,"twenty":-17.837971,"median":-8.383195,"eighty":-4.706024,"marketCap":278616174},{"date":"2023-03-10","current":-2.621609,"twenty":-17.837971,"median":-8.383195,"eighty":-4.665707,"marketCap":237819288},{"date":"2023-03-17","current":-2.783577,"twenty":-17.837971,"median":-8.383195,"eighty":-4.630686,"marketCap":252512146},{"date":"2023-03-24","current":-2.452109,"twenty":-17.837971,"median":-8.383195,"eighty":-4.578352,"marketCap":222443041},{"date":"2023-03-31","current":-2.960611,"twenty":-17.79335,"median":-8.380824,"eighty":-4.538256,"marketCap":268571782},{"date":"2023-04-06","current":-2.911644,"twenty":-17.79335,"median":-8.380824,"eighty":-4.528094,"marketCap":264129755},{"date":"2023-04-14","current":-3.066078,"twenty":-17.837971,"median":-8.383195,"eighty":-4.486449,"marketCap":278139225},{"date":"2023-04-21","current":-3.073611,"twenty":-17.837971,"median":-8.383195,"eighty":-4.430028,"marketCap":278822614},{"date":"2023-04-28","current":-3.148945,"twenty":-17.837971,"median":-8.383195,"eighty":-4.400655,"marketCap":285656501},{"date":"2023-05-05","current":-3.518079,"twenty":-17.837971,"median":-8.383195,"eighty":-4.363613,"marketCap":319142550},{"date":"2023-05-12","current":-3.66498,"twenty":-17.837971,"median":-8.383195,"eighty":-4.321917,"marketCap":332468631},{"date":"2023-05-19","current":-3.917347,"twenty":-17.837971,"median":-8.383195,"eighty":-4.262531,"marketCap":355362155},{"date":"2023-05-26","current":-3.67628,"twenty":-17.837971,"median":-8.383195,"eighty":-4.171033,"marketCap":333493714},{"date":"2023-06-02","current":-3.796813,"twenty":-17.837971,"median":-8.383195,"eighty":-4.121066,"marketCap":344427935},{"date":"2023-06-09","current":-3.762913,"twenty":-17.837971,"median":-8.383195,"eighty":-4.074132,"marketCap":341352685},{"date":"2023-06-16","current":-3.627313,"twenty":-17.837971,"median":-8.383195,"eighty":-4.015419,"marketCap":329051687},{"date":"2023-06-23","current":-3.74408,"twenty":-17.882593,"median":-8.385161,"eighty":-3.981381,"marketCap":339644213},{"date":"2023-06-30","current":-3.390012,"twenty":-17.927214,"median":-8.387126,"eighty":-3.936556,"marketCap":307524942},{"date":"2023-07-07","current":-3.371179,"twenty":-17.927214,"median":-8.387126,"eighty":-3.918102,"marketCap":305816470},{"date":"2023-07-14","current":-3.596288,"twenty":-17.927214,"median":-8.387126,"eighty":-3.881733,"marketCap":334120355},{"date":"2023-07-21","current":-3.555756,"twenty":-17.927214,"median":-8.387126,"eighty":-3.85357,"marketCap":330354654},{"date":"2023-07-28","current":-3.518909,"twenty":-17.927214,"median":-8.387126,"eighty":-3.806286,"marketCap":326931290},{"date":"2023-08-04","current":-4.078987,"twenty":-17.927214,"median":-8.383195,"eighty":-3.787773,"marketCap":378966428},{"date":"2023-08-11","current":-3.998083,"twenty":-17.927214,"median":-8.359487,"eighty":-3.787773,"marketCap":371449889},{"date":"2023-08-18","current":-4.031277,"twenty":-17.927214,"median":-8.304947,"eighty":-3.787773,"marketCap":374533883},{"date":"2023-08-25","current":-3.911409,"twenty":-17.927214,"median":-8.276306,"eighty":-3.787773,"marketCap":363397239},{"date":"2023-09-01","current":-4.001771,"twenty":-17.927214,"median":-8.250429,"eighty":-3.787773,"marketCap":371792555},{"date":"2023-09-08","current":-3.918109,"twenty":-17.612375,"median":-8.208265,"eighty":-3.787773,"marketCap":372933484},{"date":"2023-09-15","current":-3.603649,"twenty":-17.509147,"median":-8.131888,"eighty":-3.767896,"marketCap":343002476},{"date":"2023-09-22","current":-3.455454,"twenty":-17.302041,"median":-8.043907,"eighty":-3.739154,"marketCap":328897058},{"date":"2023-09-29","current":-3.491599,"twenty":-17.040221,"median":-8.003865,"eighty":-3.711696,"marketCap":332337404},{"date":"2023-10-06","current":-3.545817,"twenty":-16.78441,"median":-7.931827,"eighty":-3.68029,"marketCap":337497922},{"date":"2023-10-13","current":-3.318104,"twenty":-16.726644,"median":-7.865046,"eighty":-3.665109,"marketCap":315823744},{"date":"2023-10-20","current":-3.198825,"twenty":-16.484024,"median":-7.827443,"eighty":-3.643446,"marketCap":304470603},{"date":"2023-10-27","current":-2.909666,"twenty":-16.240274,"median":-7.800236,"eighty":-3.634846,"marketCap":276947836},{"date":"2023-11-03","current":-3.131957,"twenty":-16.139992,"median":-7.76349,"eighty":-3.619654,"marketCap":298105963},{"date":"2023-11-10","current":-2.833762,"twenty":-16.012905,"median":-7.693722,"eighty":-3.600705,"marketCap":269723110},{"date":"2023-11-17","current":-2.750628,"twenty":-15.893521,"median":-7.611776,"eighty":-3.579671,"marketCap":261810315},{"date":"2023-11-24","current":-2.945811,"twenty":-15.740872,"median":-7.585145,"eighty":-3.551016,"marketCap":280388182},{"date":"2023-12-01","current":-3.050631,"twenty":-15.367493,"median":-7.560499,"eighty":-3.53878,"marketCap":290365185},{"date":"2023-12-08","current":-3.082194,"twenty":-14.897334,"median":-7.527267,"eighty":-3.509271,"marketCap":309991619},{"date":"2023-12-15","current":-3.607919,"twenty":-14.808948,"median":-7.401044,"eighty":-3.490153,"marketCap":362866444},{"date":"2023-12-22","current":-3.8725,"twenty":-14.50411,"median":-7.357088,"eighty":-3.490153,"marketCap":389476650},{"date":"2023-12-29","current":-4.150825,"twenty":-14.108779,"median":-7.326046,"eighty":-3.488707,"marketCap":417469204},{"date":"2024-01-05","current":-4.030561,"twenty":-13.968443,"median":-7.294625,"eighty":-3.487262,"marketCap":405373656},{"date":"2024-01-12","current":-4.508181,"twenty":-13.685978,"median":-7.184004,"eighty":-3.487262,"marketCap":453410262},{"date":"2024-01-19","current":-4.281397,"twenty":-13.439469,"median":-7.118384,"eighty":-3.485816,"marketCap":430601514},{"date":"2024-01-26","current":-4.415406,"twenty":-13.314139,"median":-7.07687,"eighty":-3.487262,"marketCap":444079410},{"date":"2024-02-02","current":-5.408442,"twenty":-13.179889,"median":-7.005442,"eighty":-3.487262,"marketCap":543954079},{"date":"2024-02-09","current":-5.119809,"twenty":-12.983332,"median":-6.875358,"eighty":-3.487262,"marketCap":514924764},{"date":"2024-02-16","current":-5.071703,"twenty":-12.906354,"median":-6.785901,"eighty":-3.487262,"marketCap":510086544},{"date":"2024-02-23","current":-5.200236,"twenty":-12.550065,"median":-6.722697,"eighty":-3.487262,"marketCap":523013764},{"date":"2024-03-01","current":-5.642546,"twenty":-12.446128,"median":-6.628065,"eighty":-3.488707,"marketCap":567499036},{"date":"2024-03-08","current":-5.789293,"twenty":-12.214813,"median":-6.524463,"eighty":-3.488707,"marketCap":582258169},{"date":"2024-03-15","current":-4.84211,"twenty":-11.98198,"median":-6.473684,"eighty":-3.488707,"marketCap":524400519},{"date":"2024-03-22","current":-4.733036,"twenty":-11.754396,"median":-6.452984,"eighty":-3.488707,"marketCap":512587796},{"date":"2024-03-28","current":-4.312322,"twenty":-11.689964,"median":-6.424518,"eighty":-3.488707,"marketCap":467024436},{"date":"2024-04-05","current":-4.366859,"twenty":-11.578128,"median":-6.377487,"eighty":-3.487262,"marketCap":472930798},{"date":"2024-04-12","current":-4.713558,"twenty":-11.456327,"median":-6.282939,"eighty":-3.487262,"marketCap":510478381},{"date":"2024-04-19","current":-4.479828,"twenty":-11.332917,"median":-6.268771,"eighty":-3.487262,"marketCap":485165404},{"date":"2024-04-26","current":-4.086383,"twenty":-11.226921,"median":-6.257279,"eighty":-3.488707,"marketCap":442555225},{"date":"2024-05-03","current":-4.740827,"twenty":-11.166695,"median":-6.165345,"eighty":-3.488707,"marketCap":513431562},{"date":"2024-05-10","current":-4.709663,"twenty":-11.03278,"median":-6.075064,"eighty":-3.488707,"marketCap":510056498},{"date":"2024-05-17","current":-4.701872,"twenty":-10.939114,"median":-5.978603,"eighty":-3.488707,"marketCap":509212732},{"date":"2024-05-24","current":-4.398023,"twenty":-10.832897,"median":-5.927156,"eighty":-3.488707,"marketCap":476305861},{"date":"2024-05-31","current":-4.546052,"twenty":-10.777169,"median":-5.860731,"eighty":-3.488707,"marketCap":492337414},{"date":"2024-06-07","current":-4.549947,"twenty":-10.70117,"median":-5.823695,"eighty":-3.488707,"marketCap":492759297},{"date":"2024-06-14","current":-4.701872,"twenty":-10.638259,"median":-5.787705,"eighty":-3.488707,"marketCap":509212732},{"date":"2024-06-21","current":-4.57332,"twenty":-10.590761,"median":-5.734403,"eighty":-3.487262,"marketCap":495290595},{"date":"2024-06-28","current":-4.588902,"twenty":-10.545998,"median":-5.659081,"eighty":-3.487262,"marketCap":496978126},{"date":"2024-07-05","current":-4.592798,"twenty":-10.487182,"median":-5.601865,"eighty":-3.487262,"marketCap":497400009},{"date":"2024-07-12","current":-4.40031,"twenty":-10.410809,"median":-5.535069,"eighty":-3.487262,"marketCap":557272836},{"date":"2024-07-19","current":-4.909855,"twenty":-10.348643,"median":-5.493407,"eighty":-3.487262,"marketCap":621803663},{"date":"2024-07-26","current":-4.990842,"twenty":-10.271352,"median":-5.464346,"eighty":-3.487262,"marketCap":632060219},{"date":"2024-08-02","current":-4.444178,"twenty":-10.223016,"median":-5.409564,"eighty":-3.487262,"marketCap":562828470},{"date":"2024-08-09","current":-4.353067,"twenty":-10.163072,"median":-5.345843,"eighty":-3.487262,"marketCap":551289846},{"date":"2024-08-16","current":-4.049365,"twenty":-10.085151,"median":-5.315932,"eighty":-3.487262,"marketCap":512827764},{"date":"2024-08-23","current":-4.29649,"twenty":-10.011936,"median":-5.245231,"eighty":-3.487262,"marketCap":544124674},{"date":"2024-08-30","current":-4.555028,"twenty":-9.928269,"median":-5.200236,"eighty":-3.487262,"marketCap":576866935},{"date":"2024-09-06","current":-3.761578,"twenty":-9.858836,"median":-5.147973,"eighty":-3.487262,"marketCap":533278924},{"date":"2024-09-13","current":-3.395784,"twenty":-9.80126,"median":-5.103109,"eighty":-3.468426,"marketCap":481420358},{"date":"2024-09-20","current":-3.197646,"twenty":-9.730134,"median":-5.088884,"eighty":-3.451786,"marketCap":453330301},{"date":"2024-09-27","current":-3.761578,"twenty":-9.604413,"median":-5.050715,"eighty":-3.433767,"marketCap":533278924},{"date":"2024-10-04","current":-3.462847,"twenty":-9.550427,"median":-5.027239,"eighty":-3.433767,"marketCap":490927761},{"date":"2024-10-11","current":-3.54515,"twenty":-9.550427,"median":-4.981673,"eighty":-3.417997,"marketCap":502595939},{"date":"2024-10-18","current":-3.810351,"twenty":-9.545428,"median":-4.947656,"eighty":-3.417997,"marketCap":540193400},{"date":"2024-10-25","current":-3.560392,"twenty":-9.489729,"median":-4.917815,"eighty":-3.417997,"marketCap":504756712},{"date":"2024-11-01","current":-3.234226,"twenty":-9.457913,"median":-4.90648,"eighty":-3.408677,"marketCap":458516157},{"date":"2024-11-08","current":-3.960983,"twenty":-9.372815,"median":-4.865483,"eighty":-3.408677,"marketCap":561548535},{"date":"2024-11-15","current":-3.294455,"twenty":-9.298489,"median":-4.855149,"eighty":-3.403274,"marketCap":467054829},{"date":"2024-11-22","current":-3.523574,"twenty":-9.214148,"median":-4.816355,"eighty":-3.394581,"marketCap":499537040},{"date":"2024-11-29","current":-3.49233,"twenty":-9.137375,"median":-4.791748,"eighty":-3.394581,"marketCap":495107648},{"date":"2024-12-06","current":-3.099941,"twenty":-9.08314,"median":-4.7642,"eighty":-3.372248,"marketCap":484790442},{"date":"2024-12-13","current":-2.746023,"twenty":-8.871686,"median":-4.744722,"eighty":-3.350974,"marketCap":429442298},{"date":"2024-12-20","current":-2.641744,"twenty":-8.745815,"median":-4.72914,"eighty":-3.318939,"marketCap":413134362},{"date":"2024-12-27","current":-2.695463,"twenty":-8.664771,"median":-4.718696,"eighty":-3.301406,"marketCap":421535420},{"date":"2025-01-03","current":-2.853462,"twenty":-8.597516,"median":-4.709663,"eighty":-3.283415,"marketCap":446244413},{"date":"2025-01-10","current":-2.480585,"twenty":-8.54441,"median":-4.701872,"eighty":-3.267552,"marketCap":387931190},{"date":"2025-01-17","current":-2.622784,"twenty":-8.503884,"median":-4.677052,"eighty":-3.245933,"marketCap":410169283},{"date":"2025-01-24","current":-2.720743,"twenty":-8.466641,"median":-4.669262,"eighty":-3.229642,"marketCap":425488859},{"date":"2025-01-31","current":-2.815543,"twenty":-8.406517,"median":-4.647335,"eighty":-3.215033,"marketCap":440314255},{"date":"2025-02-07","current":-2.907182,"twenty":-8.377475,"median":-4.631753,"eighty":-3.191832,"marketCap":454645471},{"date":"2025-02-14","current":-3.084141,"twenty":-8.350549,"median":-4.619735,"eighty":-3.173524,"marketCap":482319543},{"date":"2025-02-21","current":-3.16946,"twenty":-8.304475,"median":-4.608379,"eighty":-3.162031,"marketCap":495662399},{"date":"2025-02-28","current":-3.600798,"twenty":-8.275872,"median":-4.589232,"eighty":-3.162031,"marketCap":563117950},{"date":"2025-03-07","current":-3.766697,"twenty":-8.245688,"median":-4.564425,"eighty":-3.160174,"marketCap":589062393},{"date":"2025-03-14","current":-3.561879,"twenty":-8.217238,"median":-4.553843,"eighty":-3.160174,"marketCap":626417013},{"date":"2025-03-21","current":-3.36117,"twenty":-8.217238,"median":-4.553843,"eighty":-3.160174,"marketCap":591118912},{"date":"2025-03-28","current":-3.372478,"twenty":-8.217238,"median":-4.553843,"eighty":-3.160174,"marketCap":593107537},{"date":"2025-04-04","current":-3.027597,"twenty":-8.217238,"median":-4.553843,"eighty":-3.141709,"marketCap":532454461},{"date":"2025-04-11","current":-3.248095,"twenty":-8.216635,"median":-4.542442,"eighty":-3.132319,"marketCap":571232657},{"date":"2025-04-17","current":-3.392266,"twenty":-8.216635,"median":-4.518399,"eighty":-3.132319,"marketCap":596587632},{"date":"2025-04-25","current":-3.672128,"twenty":-8.217238,"median":-4.483724,"eighty":-3.131957,"marketCap":645806111},{"date":"2025-05-02","current":-3.830434,"twenty":-8.217238,"median":-4.463511,"eighty":-3.131957,"marketCap":673646867},{"date":"2025-05-09","current":-3.363997,"twenty":-8.217238,"median":-4.440873,"eighty":-3.131957,"marketCap":591616068},{"date":"2025-05-16","current":-3.372478,"twenty":-8.217238,"median":-4.415406,"eighty":-3.131957,"marketCap":593107537},{"date":"2025-05-23","current":-3.228306,"twenty":-8.217238,"median":-4.40031,"eighty":-3.131957,"marketCap":567752563},{"date":"2025-05-30","current":-3.36117,"twenty":-8.217238,"median":-4.386336,"eighty":-3.131957,"marketCap":591118912},{"date":"2025-06-06","current":-3.901106,"twenty":-8.217238,"median":-4.373534,"eighty":-3.131957,"marketCap":686075776},{"date":"2025-06-13","current":-3.700397,"twenty":-8.217238,"median":-4.366859,"eighty":-3.131957,"marketCap":650777675},{"date":"2025-06-20","current":-3.479899,"twenty":-8.222928,"median":-4.3318,"eighty":-3.131682,"marketCap":611999479},{"date":"2025-06-27","current":-3.250922,"twenty":-8.222928,"median":-4.314723,"eighty":-3.131682,"marketCap":571729814},{"date":"2025-07-03","current":-3.386612,"twenty":-8.222928,"median":-4.300635,"eighty":-3.131682,"marketCap":595593319},{"date":"2025-07-11","current":-4.20733,"twenty":-8.222928,"median":-4.287148,"eighty":-3.131682,"marketCap":771809364},{"date":"2025-07-18","current":-4.342962,"twenty":-8.222928,"median":-4.27265,"eighty":-3.131682,"marketCap":796690388},{"date":"2025-07-25","current":-4.231743,"twenty":-8.222928,"median":-4.248806,"eighty":-3.131682,"marketCap":776287948},{"date":"2025-08-01","current":-3.69735,"twenty":-8.222928,"median":-4.224101,"eighty":-3.131682,"marketCap":678256714},{"date":"2025-08-08","current":-3.434223,"twenty":-8.222928,"median":-4.216401,"eighty":-3.131682,"marketCap":629987527},{"date":"2025-08-15","current":-3.51289,"twenty":-8.222928,"median":-4.192768,"eighty":-3.131682,"marketCap":644418521},{"date":"2025-08-22","current":-3.529145,"twenty":-8.204398,"median":-4.170246,"eighty":-3.131682,"marketCap":647400457},{"date":"2025-08-29","current":-3.707349,"twenty":-8.168957,"median":-4.130686,"eighty":-3.131682,"marketCap":680091008},{"date":"2025-09-05","current":-4.171111,"twenty":-8.177575,"median":-4.106137,"eighty":-3.131408,"marketCap":765165309},{"date":"2025-09-12","current":-3.684199,"twenty":-8.116715,"median":-4.106137,"eighty":-3.131682,"marketCap":748249687},{"date":"2025-09-19","current":-3.452848,"twenty":-8.116715,"median":-4.078822,"eighty":-3.131682,"marketCap":701263043},{"date":"2025-09-26","current":-3.008804,"twenty":-8.116715,"median":-4.061095,"eighty":-3.130143,"marketCap":611078999},{"date":"2025-10-03","current":-2.92298,"twenty":-8.116715,"median":-4.047697,"eighty":-3.102006,"marketCap":593648469},{"date":"2025-10-10","current":-2.937906,"twenty":-8.116715,"median":-4.030919,"eighty":-3.090104,"marketCap":596679865},{"date":"2025-10-17","current":-2.746357,"twenty":-8.047278,"median":-4.012645,"eighty":-3.08457,"marketCap":557776944},{"date":"2025-10-24","current":-2.736407,"twenty":-7.935623,"median":-3.99841,"eighty":-3.073352,"marketCap":555756014},{"date":"2025-10-31","current":-2.728944,"twenty":-7.853444,"median":-3.981381,"eighty":-3.058674,"marketCap":554240315},{"date":"2025-11-07","current":-2.709043,"twenty":-7.725057,"median":-3.970212,"eighty":-3.042702,"marketCap":550198453},{"date":"2025-11-14","current":-3.257808,"twenty":-7.558621,"median":-3.949337,"eighty":-3.035234,"marketCap":661650975},{"date":"2025-11-21","current":-3.240386,"twenty":-7.343932,"median":-3.927885,"eighty":-3.035234,"marketCap":658112734},{"date":"2025-11-28","current":-3.601259,"twenty":-7.111083,"median":-3.922265,"eighty":-3.035234,"marketCap":731404859},{"date":"2025-12-05","current":-4.081593,"twenty":-6.578869,"median":-3.9153,"eighty":-3.035234,"marketCap":828959205},{"date":"2025-12-12","current":-4.206031,"twenty":-6.450633,"median":-3.9153,"eighty":-3.035234,"marketCap":854232351},{"date":"2025-12-19","current":-3.733164,"twenty":-6.385563,"median":-3.910611,"eighty":-3.035234,"marketCap":758194395},{"date":"2025-12-26","current":-3.929777,"twenty":-6.292131,"median":-3.909499,"eighty":-3.035234,"marketCap":798125966},{"date":"2026-01-02","current":-4.019373,"twenty":-6.170495,"median":-3.90582,"eighty":-3.035234,"marketCap":816322631},{"date":"2026-01-09","current":-3.937244,"twenty":-6.047814,"median":-3.902294,"eighty":-3.035234,"marketCap":799642355},{"date":"2026-01-16","current":-3.723209,"twenty":-5.848209,"median":-3.896085,"eighty":-3.035234,"marketCap":756172543},{"date":"2026-01-23","current":-4.116435,"twenty":-5.781026,"median":-3.889172,"eighty":-3.035234,"marketCap":836035686},{"date":"2026-01-30","current":-3.894934,"twenty":-5.662941,"median":-3.874645,"eighty":-3.035234,"marketCap":791049485},{"date":"2026-02-06","current":-3.583837,"twenty":-5.563204,"median":-3.865345,"eighty":-3.035234,"marketCap":727866619},{"date":"2026-02-13","current":-3.763029,"twenty":-5.513485,"median":-3.848771,"eighty":-3.035234,"marketCap":764259950},{"date":"2026-02-20","current":-3.954665,"twenty":-5.480203,"median":-3.839524,"eighty":-3.035234,"marketCap":803180595},{"date":"2026-02-27","current":-3.922311,"twenty":-5.441241,"median":-3.839524,"eighty":-3.035234,"marketCap":796609577},{"date":"2026-03-06","current":-4.034306,"twenty":-5.385594,"median":-3.839524,"eighty":-3.035234,"marketCap":819355409},{"date":"2026-03-13","current":-4.325493,"twenty":-5.328819,"median":-3.839524,"eighty":-3.035234,"marketCap":878494572},{"date":"2026-03-20","current":-4.089059,"twenty":-5.279687,"median":-3.839524,"eighty":-3.035234,"marketCap":830475593}],"updateTime":1774176567098},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KALV\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582638624","title":"Kalvista Pharmaceuticals Inc - Qtrly Net Loss per Share, Basic and Diluted $0.92","url":"https://stock-news.laohu8.com/highlight/detail?id=2582638624","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582638624?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:30","pubTimestamp":1762810200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUABHG9KK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2582538622","title":"Kalvista Pharmaceuticals Inc - Net Product Revenue $13.7 Mln in Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2582538622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582538622?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:30","pubTimestamp":1762810200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUABHG9KK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2582388013","title":"Top News Today/Canada: Barrick's Interim CEO Gets to Work","url":"https://stock-news.laohu8.com/highlight/detail?id=2582388013","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582388013?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:30","pubTimestamp":1762810200,"startTime":"0","endTime":"0","summary":"Barrick Looks to Get Handle on North American Operations, Find Growth. Barrick Mining is diving into how its core gold operations in Nevada are being run and is looking for opportunities to boost production, steps that come after parting ways with its former chief executive.Mark Hill, Barrick's interim CEO, said that the mining company is determined to grow and not just replace the resources it digs up, and to produce gold and copper safely.Since taking on the role and being named chief operating officer in late September, Hill said he has met with Barrick's teams around the world. He also spent several weeks in Nevada, which alongside an asset in the Dominican Republic, is a focus of the company's review.Barrick Looking to Reset Safety Culture  Barrick Continues Efforts to Free Workers Jailed in Mali. Burger King Strikes Joint Venture to Double Presence in China. C2AE offers a range of engineering services to clients including state and local governments, transportation agencies, and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVI","SND","BK4138","BK4168","BK4021","NRDE","BK4023","IE00BFMHRM44.USD","SLSN","CENN","MVIS","AMTX","NMM","BK4079","LU0205193047.USD","DOX","MGTX","MGNX","BK4179","LPTH","BK4134","CLDX","BK4547","BK4109","FTHM","LU0205194284.USD","PVLA","BK4137","WKHS","BK4139","ATOS","BK4099","GNPX","IPSC","BK4505","PRLD","BK4539","STXS","WHLM","SYPR","KALV","BK4082","BK4551","ATRA","GIFI","QUIK","SSTI","CRBU","ACCS"],"gpt_icon":1},{"id":"2581093605","title":"KalVista Unveils New Data Showing High Patient Satisfaction With Oral HAE Drug EKTERLY","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093605","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093605?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:03","pubTimestamp":1762434232,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has announced new data from clinical studies of EKTERLY , the first and only oral on-demand treatment for hereditary angioedema . The results, which include patient satisfaction and pediatric data, as well as physician and patient survey and consensus study data, were presented at the American College of Allergy, Asthma & Immunology  2025 Annual Scientific Meeting held from November 6-10, 2025. The findings highlight patient satisfaction with EKTERLY, particularly among those transitioning from injectable therapies, and suggest a potential role for the drug in pediatric patients aged 2-11. According to the company, these results underscore an unmet need for safe, effective, and easy-to-use on-demand HAE treatments. Further details and links to the presentations are available on the KalVista website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely info","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL8XplG5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2581972154","title":"KalVista Pharmaceuticals to Present at Stifel Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2581972154","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581972154?lang=en_us&edition=fundamental","pubTime":"2025-11-05 20:00","pubTimestamp":1762344024,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. will participate in a fireside chat at the Stifel 2025 Healthcare Conference on November 12, 2025, at 8:40 a.m. EST. The live audio webcast will be available on the company's investor website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on November 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDLbKNNJj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","SF","BK4139","BK4127"],"gpt_icon":0},{"id":"2580297302","title":"Kalvista Pharmaceuticals Inc. to Release Third Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2580297302","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580297302?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171220,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on November 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL49wpCp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2580297840","title":"Kalvista Pharmaceuticals to Host Third Quarter Financial Results Conference Call and Webcast on November 11, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2580297840","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580297840?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA5C1FGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2577204399","title":"KalVista price target lowered to $29 from $36 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2577204399","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577204399?lang=en_us&edition=fundamental","pubTime":"2025-10-22 23:30","pubTimestamp":1761147035,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on KalVista (KALV) to $29 from $36 and keeps a Buy rating on the shares. The firm adjusted targets among its s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kalvista-price-target-lowered-to-29-from-36-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kalvista-price-target-lowered-to-29-from-36-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2577395396","title":"BofA Securities Adjusts KalVista Pharmaceuticals Price Target to $29 From $36, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2577395396","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577395396?lang=en_us&edition=fundamental","pubTime":"2025-10-22 22:17","pubTimestamp":1761142670,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals (KALV) has an average rating of Buy and mean price target of $30.78, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2577439864","title":"Kalvista Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $29 From $36","url":"https://stock-news.laohu8.com/highlight/detail?id=2577439864","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577439864?lang=en_us&edition=fundamental","pubTime":"2025-10-22 21:48","pubTimestamp":1761140929,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nFWN3W338P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2574905703","title":"KalVista Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Operations Officer Arif Bilal","url":"https://stock-news.laohu8.com/highlight/detail?id=2574905703","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574905703?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:59","pubTimestamp":1759964353,"startTime":"0","endTime":"0","summary":"Kalvista Pharmaceuticals Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Arif Bilal, Chief Operations Officer, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL1ZT3NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2573684988","title":"KalVista Pharmaceuticals Announces Positive Clinical Data and European Launch of EKTERLY®, the First Oral On-Demand Treatment for Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2573684988","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573684988?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:00","pubTimestamp":1759780818,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Announces Positive Clinical Data and European Launch of EKTERLY, the First Oral On-Demand Treatment for Hereditary Angioedema. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on October 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDLc1k6wY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2573624679","title":"KalVista Pharmaceuticals Appoints Bilal Arif as COO and Linea Aspesi as Chief People Officer Amid Global EKTERLY Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2573624679","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573624679?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748437,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has appointed Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025. The new appointments come as the company prepares for the global launch of EKTERLY, its therapy for hereditary angioedema. Arif brings over 25 years of biopharmaceutical operations experience, previously serving at Sarepta Therapeutics and Momenta Pharmaceuticals. Aspesi joins as KalVista expands its organizational and people strategies to support business growth.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on October 06, 2025, and is solely responsible for the information ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDLbsYtSc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU0122379950.USD","LU1162221912.USD","JNJ","IE00BN8TJ469.HKD","LU1935042991.SGD","LU2430703178.SGD","IE00B3T34201.USD","IE00BJJMRZ35.SGD","LU1261432733.SGD","BK4568","BK4592","LU2129689605.HKD","LU0640476718.USD","LU2602419157.SGD","LU1732799900.SGD","LU0203345920.USD","LU1778281490.HKD","LU2129689431.USD","LU2592432038.USD","KALV","IE00BDGV0183.EUR","LU1074936037.SGD","LU1032466523.USD","IE0009355771.USD","LU2129689514.USD","LU2430703251.USD","IE0002270589.USD","LU1066051225.USD","LU1894683264.USD","LU1585245621.USD","LU1430594728.SGD","IE0034235303.USD","LU0466842654.USD","BK4504","LU2347655156.SGD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU0795875169.SGD","IE00BVYPNW00.USD","SRPT","LU1280957306.USD","IE00BBT3K403.USD","LU0203347892.USD","LU2430703095.HKD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU0098860793.USD","LU1032955483.USD","BK4007"],"gpt_icon":0},{"id":"2573679636","title":"Kalvista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2573679636","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573679636?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:00","pubTimestamp":1759748401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA1Y1PHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2572501990","title":"KalVista Pharmaceuticals Grants Stock Options to New Employees Under Inducement Equity Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2572501990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572501990?lang=en_us&edition=fundamental","pubTime":"2025-10-03 19:00","pubTimestamp":1759489215,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has announced the granting of inducement stock options to two newly-hired employees. The options allow the purchase of a total of 30,000 shares of KalVista common stock, with the exercise price set at the closing price on the first day a closing price is reported after the grant date. One-fourth of the options will vest on the first anniversary of the vesting start date, with the remainder vesting in equal monthly installments over the following three years. Each option carries a 10-year term and is governed by KalVista's Inducement Equity Incentive Plan and a stock option agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL5YtClk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2572548519","title":"KalVista Pharmaceuticals Appoints Bethany L. Sensenig to Board of Directors and Audit Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2572548519","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572548519?lang=en_us&edition=fundamental","pubTime":"2025-10-02 19:00","pubTimestamp":1759402833,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has appointed Bethany L. Sensenig to its Board of Directors, effective October 1, 2025. Sensenig will also join the Audit Committee. Nancy Stuart will step down from the Audit Committee but will remain on the Board and join the Compensation Committee. Sensenig is currently CFO and Head of Operations at Radius Health, Inc. and has previously held leadership roles at 9 Meters Biopharma, Minovia Therapeutics, and Biogen Inc.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on October 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nNDL8fSt0w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00B894F039.SGD","NMTRQ","BK4588","BK4533","LU0234570918.USD","BK4139","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0889565916.HKD","BK4532","BK4007","BIIB","KALV","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2572519518","title":"Kalvista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2572519518","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572519518?lang=en_us&edition=fundamental","pubTime":"2025-10-02 19:00","pubTimestamp":1759402800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nTUAWQJG9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2572538448","title":"H.C. Wainwright Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572538448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572538448?lang=en_us&edition=fundamental","pubTime":"2025-10-01 18:36","pubTimestamp":1759314961,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on KalVista Pharmaceuticals today and set a price target of $27.00. The company’s share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-kalvista-pharmaceuticals-kalv-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-kalvista-pharmaceuticals-kalv-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KALV"],"gpt_icon":0},{"id":"2571350723","title":"KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, with Option for Additional $15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2571350723","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571350723?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:28","pubTimestamp":1759177703,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Announces Proposed $110 Million Convertible Senior Notes Offering, with Option for Additional $15 Million. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL5rmhVF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2570076970","title":"KalVista Pharmaceuticals Announces New Clinical Data on EKTERLY® (Sebetralstat) for Hereditary Angioedema at German Allergy Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2570076970","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570076970?lang=en_us&edition=fundamental","pubTime":"2025-09-26 19:00","pubTimestamp":1758884436,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Announces New Clinical Data on EKTERLY  for Hereditary Angioedema at German Allergy Congress. KalVista Pharmaceuticals Inc. has announced the acceptance of six abstracts for ePoster presentation at the upcoming 20th German Allergy Congress, scheduled to take place in Düsseldorf, Germany, from October 2-4, 2025. The presentations will cover new data on EKTERLY , including its use for the on-demand treatment of hereditary angioedema  attacks, its impact on anxiety associated with HAE, and its effectiveness in patients already receiving berotralstat. The results from these studies will be presented at the congress, with further details and links to all presentations available on the KalVista website under Publications.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDL2ZcShV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":67,"code":"91000000","status":"200"}]}}